ARCHIVES

Sen. Dole Raps HEW Over Delays On Patent Requests

This article is from The Cancer Letter archive.

Vol. 04 No. 32 | August 11, 1978

Download PDF Visit The Full Archive

Related Articles

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

May 2, 2008

European Commission Approves Subcutaneous Rituximab

March 28, 2014

NCAB Action On Diet FIT “Not Cavalier,” Chairman Korn Says

November 10, 1989

MSKCC oncologist settles insider trading case with SEC.

November 11, 2005